Body mass index: A risk factor for retinopathy in type 2 diabetic patients

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Kaštelan, Snježana ^a   Tomić, Martina ^b   Gverović Antunica, Antonela ^c   Ljubić, Spomenka ^b   Salopek Rabatić, Jasminka ^a   Karabatić, Mirela ^d  

^a University of Zagreb School of Medicine   (Croatia)

^b University of Zagreb   (Croatia)

^c Dubrovnik General Hospital   (Croatia)

^d University of Applied Science Velika Gorica   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DETERIORATION; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; MIDDLE AGED;

AGED; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84890091611     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/436329     Document Type: Article

References (73)

1. Friedman N., Fanning E. L., Overweight and obesity: an overview of prevalence, clinical impact, and economic impact. Disease Management 2004 7 1 S1 S6 2-s2.0-6344225832
2. Haslam D. W., James W. P. T., Obesity. The Lancet 2005 366 9492 1197 1209 2-s2.0-25844457693 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
3. James P. T., Obesity: the worldwide epidemic. Clinics in Dermatology 2004 22 4 276 280 2-s2.0-4744339348 10.1016/j.clindermatol.2004.01.010 (Pubitemid 39314611)
4. Formiguera X., Cantón A., Obesity: epidemiology and clinical aspects. Best Practice and Research 2004 18 6 1125 1146 2-s2.0-8744249039 10.1016/j.bpg.2004.06.030 (Pubitemid 39517697)
5. Van Dieren S., Beulens J. W. J., Van Der Schouw Y. T., Grobbee D. E., Neal B., The global burden of diabetes and its complications: an emerging pandemic. European Journal of Cardiovascular Prevention and Rehabilitation 2010 17 1, supplement S3 S8 2-s2.0-77952907032 10.1097/01.hjr.0000368191.86614.5a
6. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
7. Roglic G., Unwin N., Bennett P. H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H., The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005 28 9 2130 2135 2-s2.0-24144472565 10.2337/diacare.28.9.2130 (Pubitemid 41242456)
8. Moss S. E., Klein R., Klein B. E. K., The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998 105 6 998 1003 2-s2.0-0031807908 10.1016/S0161-6420(98)96025-0 (Pubitemid 28268322)
9. Aiello L. M., Perspectives on diabetic retinopathy. American Journal of Ophthalmology 2003 136 1 122 135 2-s2.0-0038016408 10.1016/S0002-9394(03)00219-8 (Pubitemid 36794505)
10. Harris M. I., Klein R., Welborn T. A., Knuiman M. W., Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992 15 7 815 819 2-s2.0-0026735891
11. Turner R., Cull C., Holman R., United Kingdom prospective diabetes study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Annals of Internal Medicine 1996 124 1 136 145 2-s2.0-0030034518 (Pubitemid 26011611)
12. Diabetes Control and Complication Trial / Epidemiology of Diabetes Interventions and Complications Research Group, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. New England Journal of Medicine 2000 342 6 381 389
13. Stratton I. M., Kohner E. M., Aldington S. J., Turner R. C., Holman R. R., Manley S. E., Matthews D. R., UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001 44 2 156 163 2-s2.0-0035134120 10.1007/s001250051594 (Pubitemid 32156199)
14. Kaštelan S., Tomić M., Pavan J., Orešković S., Maternal immune system adaptation to pregnancy-a potential influence on the course of diabetic retinopathy. Reproductive Biology and Endocrinology 2010 8 124
15. Beulens J. W. J., Patel A., Vingerling J. R., Cruickshank J. K., Hughes A. D., Stanton A., Lu J., McG Thom S. A., Grobbee D. E., Stolk R. P., Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia 2009 52 10 2027 2036 2-s2.0-69949166204 10.1007/s00125-009-1457-x
16. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H. Jr., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet 2010 376 9739 419 430 2-s2.0-77955585592 10.1016/S0140-6736(10)60576-4
17. Cheung N., Wong T. Y., Obesity and eye diseases. Survey of Ophthalmology 2007 52 2 180 195 2-s2.0-33847693532 10.1016/j.survophthal.2006.12.003 (Pubitemid 46371493)
18. Chaturvedi N., Fuller J. H., Jarrett R. J., Keen H., Morrish N. J., Watkins P. J., Teuscher A., Teuscher T., Studer P. P., Diem P., Czyzyk A., Janeczko D., Kopczynski J., Raskovic M., Schliack V., Ratzmann K. P., Aganovic I., Skrabolo A., Stavljenic A., Mortality risk by body weight and weight change in people with NIDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 1995 18 6 766 774 2-s2.0-0029043436
19. Henricsson M., Nyström L., Blohmé G., Östman J., Kullberg C., Svensson M., Schölin A., Arnqvist H. J., Björk E., Bolinder J., Eriksson J. W., Sundkvist G., The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003 26 2 349 354 2-s2.0-0038525261 10.2337/diacare.26.2.349 (Pubitemid 36929054)
20. Turner R., Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998 352 9131 854 865 2-s2.0-0032511566 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
21. Van Leiden H. A., Dekker J. M., Moll A. C., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Polak B. C. P., Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Archives of Ophthalmology 2003 121 2 245 251 2-s2.0-0037314210 (Pubitemid 36184039)
22. Dirani M., Xie J., Fenwick E., Benarous R., Rees G., Wong T. Y., Lamoureux E. L., Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Investigative Ophthalmology & Visual Science 2011 52 7 4416 4421 2-s2.0-80052341866
23. Katušić D., Tomić M., Jukić T., Obesity-a risk factor for diabetic retinopathy in type 2 diabetes? Collegium Antropologicum 2005 29 supplement 47 50 (Pubitemid 41265098)
24. Zhang L., Krzentowski G., Albert A., Lefebvre P. J., Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001 24 7 1275 1279 2-s2.0-0035405824 (Pubitemid 33716411)
25. Li X., Wang Z., Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Experimental and Therapeutic Medicine 2013 5 5 1393 1396
26. De Block C. E. M., De Leeuw I. H., Van Gaal L. F., Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 2005 28 7 1649 1655 2-s2.0-24944459905 10.2337/diacare.28.7.1649 (Pubitemid 41340904)
27. Klein R., Klein B. E. K., Moss S. E., Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of diabetic retinopathy. Archives of Internal Medicine 1997 157 6 650 656 2-s2.0-0030945163 (Pubitemid 27133195)
28. Klein R., Klein B. E. K., Moss S. E., The Wisconsin epidemiologic study of diabetic retinopathy-III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology 1984 102 4 527 532 2-s2.0-0021191759 (Pubitemid 14127839)
29. Lim L. S., Shyong Tai E., Mitchell P., Wang J. J., Tay W. T., Lamoureux E., Wong T. Y., C-reactive protein, body mass index, and diabetic retinopathy. Investigative Ophthalmology and Visual Science 2010 51 9 4458 4463 2-s2.0-77957339847 10.1167/iovs.09-4939
30. Raman R., Rani P. K., Gnanamoorthy P., Sudhir R. R., Kumaramanikavel G., Sharma T., Association of obesity with diabetic retinopathy: Sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetologica 2010 47 3 209 215 2-s2.0-77955663714 10.1007/s00592-009-0113-8
31. Dowse G. K., Humphrey A. R. G., Collins V. R., Plehwe W., Gareeboo H., Fareed D., Hemraj F., Taylor H. R., Tuomilehto J., Alberti K. G. M. M., Zimmet P. Z., Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American Journal of Epidemiology 1998 147 5 448 457 2-s2.0-18144442999 (Pubitemid 28146104)
32. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2007 30 supplement 1 S42 S47
33. 1c: standardizacija 'zlatnog standarda'. Biochemia Medica 2006 16 1 25 36 (Pubitemid 44043889)
34. Demacker P. N. M., Boerma G. J. M., Baadenhuijsen H., Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clinical Chemistry 1983 29 11 1916 1922 2-s2.0-0020603512 (Pubitemid 13023978)
35. McGowan M. W., Artiss J. D., Strandbergh D. R., Zak B., A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clinical Chemistry 1983 29 3 538 542 2-s2.0-0020680990 (Pubitemid 13160770)
36. Kumanyika S. K., Obarzanek E., Stettler N., Bell R., Field A. E., Fortmann S. P., Franklin B. A., Gillman M. W., Lewis C. E., Poston W. C., Stevens J., Hong Y., Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (formerly the expert panel on population and prevention science). Circulation 2008 118 4 428 464 2-s2.0-49149109159 10.1161/CIRCULATIONAHA.108.189702
37. Aldington S. J., Kohner E. M., Meuer S., Klein R., Sjolie A. K., Methodology for retinal photography and assessment of diabetic retinography: the EURODIAB IDDM complications study. Diabetologia 1995 38 4 437 444 2-s2.0-0028938980 10.1007/s001250050303
38. Sokal R. R., Rohlf F. J., Biometry: The Principles and Practice of Statistics in Biological Research 1995 3rd New York, NY, USA W. H. Freeman and Co.
39. StatSoft, Inc, Electronic Statistics Textbook. StatSoft, Tulsa, Okla, USA, 2011, http://www.statsoft.com/textbook
40. Yau J. W. Y., Rogers S. L., Kawasaki R., Lamoureux E. L., Kowalski J. W., Bek T., Chen S.-J., Dekker J. M., Fletcher A., Grauslund J., Haffner S., Hamman R. F., Ikram M. K., Kayama T., Klein B. E. K., Klein R., Krishnaiah S., Mayurasakorn K., O'Hare J. P., Orchard T. J., Porta M., Rema M., Roy M. S., Sharma T., Shaw J., Taylor H., Tielsch J. M., Varma R., Wang J. J., Wang N., West S., Zu L., Yasuda M., Zhang X., Mitchell P., Wong T. Y., Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012 35 3 556 564 2-s2.0-84859030420 10.2337/dc11-1909
41. Tapp R. J., Shaw J. E., Harper C. A., De Courten M. P., Balkau B., McCarty D. J., Taylor H. R., Welborn T. A., The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003 26 6 1731 1737 2-s2.0-0042168981 10.2337/diacare.26.6.1731 (Pubitemid 36929112)
42. Williams R., Airey M., Baxter H., Forrester J., Kennedy-Martin T., Girach A., Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004 18 10 963 983 2-s2.0-7244240730 10.1038/sj.eye.6701476 (Pubitemid 39430033)
43. Moss S. E., Klein R., Klein B. E. K., Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994 101 6 1061 1070 2-s2.0-0028275559 (Pubitemid 24183163)
44. Matthews D. R., Stratton I. M., Aldington S. J., Holman R. R., Kohner E. M., Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Archives of Ophthalmology 2004 122 11 1631 1640 2-s2.0-8144221037 10.1001/archopht.122.11. 1631 (Pubitemid 39473407)
45. Schrier R. W., Estacio R. O., Mehler P. S., Hiatt W. R., Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nature Clinical Practice Nephrology 2007 3 8 428 438 2-s2.0-34547232484 10.1038/ncpneph0559 (Pubitemid 47123588)
46. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC VII report. Journal of the American Medical Association 2003 289 19 2560 2572
47. Zanchetti A., Guidelines for the management of arterial hypertension. Journal of Hypertension 2003 21 6 1011 1053 2-s2.0-0037527647 10.1097/00004872-200306000-00001 (Pubitemid 36667855)
48. The diabetes control and complications trial research group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993 329 14 977 986
49. Reichard P., Nilsson B.-Y., Rosenqvist U., The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New England Journal of Medicine 1993 329 5 304 309 2-s2.0-0027275397 10.1056/NEJM199307293290502 (Pubitemid 23210681)
50. Gray A., Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. British Medical Journal 1998 317 7160 720 726 2-s2.0-7344263454 (Pubitemid 28414302)
51. Calle E. E., Thun M. J., Petrelli J. M., Rodriguez C., Heath C. W. Jr., Body-mass index and mortality in a prospective cohort of U.S. adults. New England Journal of Medicine 1999 341 15 1097 1105 2-s2.0-0033533859 10.1056/NEJM199910073411501 (Pubitemid 29466221)
52. Haupt E., Benecke A., Haupt A., Herrmann R., Vogel H., Walter C., The KID study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession, prevalence and correlation with duration of diabetic state, BMI and C-peptide. Experimental and Clinical Endocrinology and Diabetes 1999 107 7 435 441 2-s2.0-0032703483
53. Dorchy H., Claes C., Verougstraete C., Risk factors of developing proliferative retinopathy in type 1 diabetic patients: role of BMI. Diabetes Care 2002 25 4 798 799 2-s2.0-0036548892
54. Silha J. V., Krsek M., Sucharda P., Murphy L. J., Angiogenic factors are elevated in overweight and obese individuals. International Journal of Obesity 2005 29 11 1308 1314 2-s2.0-27944453623 10.1038/sj.ijo.0802987 (Pubitemid 41679261)
55. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 1994 331 22 1480 1487 2-s2.0-0027942607 10.1056/NEJM199412013312203 (Pubitemid 24356306)
56. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Saito Y., Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003 46 11 1483 1488 2-s2.0-0345117960 10.1007/s00125-003-1221-6 (Pubitemid 37518569)
57. van Greevenbroek M. M. J., Schalkwijk C. G., Stehouwer C. D. A., Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. The Netherlands Journal of Medicine 2013 71 4 174 187
58. Kwon H., Pessin J. E., Adipokines mediate inflammation and insulin resistance. Frontiers in Endocrinology 2013 4 71 1 13
59. Fuentes E., Fuentes F., Vilahur G., Badimon L., Palomo I., Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators of Inflammation 2013 2013 11 136584 10.1155/2013/136584
60. Van Gaal L. F., Mertens I. L., De Block C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 7121 875 880 2-s2.0-33845914986 10.1038/nature05487 (Pubitemid 46028447)
61. Uckaya G., Ozata M., Bayraktar Z., Erten V., Bingol N., Ozdemir I. C., Is leptin associated with diabetic retinopathy? Diabetes Care 2000 23 3 371 376 2-s2.0-0034007677 (Pubitemid 30131747)
62. Matsuda M., Kawasaki F., Yamada K., Kanda Y., Saito M., Eto M., Matsuki M., Kaku K., Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabetic Medicine 2004 21 8 881 888 2-s2.0-3843111317 10.1111/j.1464-5491.2004.01261.x (Pubitemid 39037002)
63. Sierra-Honigmann M. R., Nath A. K., Murakami C., García- Cardeña G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J., Flores-Riveros J. R., Biological action of leptin as an angiogenic factor. Science 1998 281 5383 1683 1686 2-s2.0-0032508682 10.1126/science.281.5383.1683 (Pubitemid 28435586)
64. Fernández-Real J. M., Botas-Cervero P., López-Bermano A., Casamitjana R., Funahashi T., Delgado E., Kihara S., Ricart W., Adiponectin is independently associated with glycosylated haemoglobin. European Journal of Endocrinology 2004 150 2 201 205 2-s2.0-1542726353 10.1530/eje.0.1500201 (Pubitemid 38331903)
65. Ferris F. L., Chew E. Y., Hoogwerf B. J., Serum lipids and diabetic retinopathy. Diabetes Care 1996 19 11 1291 1293 2-s2.0-0030280257 (Pubitemid 126752469)
66. Klein R., Sharrett A. R., Klein B. E. K., Moss S. E., Folsom A. R., Wong T. Y., Brancati F. L., Hubbard L. D., Couper D., The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 2002 109 7 1225 1234 2-s2.0-0036288905 10.1016/S0161-6420(02)01074-6 (Pubitemid 34700911)
67. Kohner E. M., Aldington S. J., Stratton I. M., Manley S. E., Holman R. R., Matthews D. R., Turner R. C., United kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Archives of Ophthalmology 1998 116 3 297 303 2-s2.0-0031916725
68. Wong T. Y., Duncan B. B., Golden S. H., Klein R., Couper D. J., Klein B. E. K., Hubbard L. D., Sharrett A. R., Schmidt M. I., Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Investigative Ophthalmology & Visual Science 2004 45 9 2949 2954 2-s2.0-4344667580 10.1167/iovs.04-0069 (Pubitemid 39121821)
69. Tomić M., Ljubić S., Kaštelan S., The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Collegium Antropologicum 2013 37, supplement 1 51 57
70. Khavandi K., Amer H., Ibrahim B., Brownrigg J., Strategies for preventing type 2 diabetes: an update for clinicians. Therapeutic Advances in Chronic Disease 2013 4 5 242 261
71. Sheard N. F., Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutrition Reviews 2003 61 2 76 79 2-s2.0-0038345004 10.1301/nr.2003.febr.76-79 (Pubitemid 37259969)
72. Sjöström L., Lindroos A.-K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., Dahlgren S., Larsson B., Narbro K., Sjöström C. D., Sullivan M., Wedel H., Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 26 2683 2693 2-s2.0-10844295087 10.1056/NEJMoa035622 (Pubitemid 39665322)
73. Zanella M. T., Kohlmann O. Jr., Ribeiro A. B., Treatment of obesity hypertension and diabetes syndrome. Hypertension 2001 38 3 705 708 2-s2.0-0035461789